2w1i
From Proteopedia
(Difference between revisions)
m (Protected "2w1i" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | [[Image:2w1i.png|left|200px]] | ||
- | |||
{{STRUCTURE_2w1i| PDB=2w1i | SCENE= }} | {{STRUCTURE_2w1i| PDB=2w1i | SCENE= }} | ||
- | |||
===STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR=== | ===STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR=== | ||
- | |||
{{ABSTRACT_PUBMED_19143567}} | {{ABSTRACT_PUBMED_19143567}} | ||
Line 11: | Line 7: | ||
==Reference== | ==Reference== | ||
- | <ref group="xtra">PMID:019143567</ref><references group="xtra"/> | + | <ref group="xtra">PMID:019143567</ref><references group="xtra"/><references/> |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Non-specific protein-tyrosine kinase]] | [[Category: Non-specific protein-tyrosine kinase]] |
Revision as of 19:00, 24 March 2013
STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
Template:ABSTRACT PUBMED 19143567
About this Structure
2w1i is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Howard S, Berdini V, Boulstridge JA, Carr MG, Cross DM, Curry J, Devine LA, Early TR, Fazal L, Gill AL, Heathcote M, Maman S, Matthews JE, McMenamin RL, Navarro EF, O'Brien MA, O'Reilly M, Rees DC, Reule M, Tisi D, Williams G, Vinkovic M, Wyatt PG. Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity. J Med Chem. 2009 Jan 22;52(2):379-88. PMID:19143567 doi:10.1021/jm800984v
Categories: Homo sapiens | Non-specific protein-tyrosine kinase | Berdini, V. | Boulstridge, J A. | Brien, M A.O. | Carr, M G. | Cross, D M. | Curry, J. | Devine, L A. | Early, T R. | Fazal, L. | Gill, A L. | Heathcote, M. | Howard, S. | Maman, S. | Matthews, J E. | Mcmenamin, R L. | Navarro, E F. | Rees, D C. | Reilly, M O. | Reule, M. | Tisi, D. | Vinkovic, M. | Williams, G. | Wyatt, P G. | Atp-binding | Aurora | Cancer | Disease mutation | Inhibitor | Kinase | Membrane | Nucleotide-binding | Phosphoprotein | Proto-oncogene | Sh2 domain | Transferase | Tyrosine-protein kinase